Zynex, Inc. (ZYXI)

Market Cap	345.08M
Revenue (ttm)	188.68M
Net Income (ttm)	8.17M
Shares Out	31.78M
EPS (ttm)	0.23
PE Ratio	47.22
Forward PE	18.41
Dividend	n/a
Ex-Dividend Date	n/a

Volume	92,404
Open	11.03
Previous Close	10.68
Day's Range	10.70 - 11.03
52-Week Range	6.88 - 13.77
Beta	0.49
Analysts	Strong Buy
Price Target	18.00 (+65.75%)
Earnings Date	Apr 30, 2024

About ZYXI

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology de...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1996
• Employees: 1,100
• Stock Exchange: NASDAQ
• Ticker Symbol: ZYXI

Financial Performance

In 2023, Zynex's revenue was $184.32 million, an increase of 16.54% compared to the previous year's $158.17 million. Earnings were $9.73 million, a decrease of -42.91%.

Analyst Forecast

According to 2 analysts, the average rating for ZYXI stock is "Strong Buy." The 12-month stock price forecast is $18.0, which is an increase of 65.75% from the latest price.

Price Target

$18.0

(65.75% upside)

Analyst Consensus: Strong Buy